Tower Research Capital (TRC)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.1M | Buy |
|
|||||
|
2025
Q2 | $497K | Sell |
|
|||||
|
2025
Q1 | $3.23M | Sell |
|
|||||
|
2024
Q4 | $6.03M | Buy |
|
|||||
|
2024
Q3 | $3.67M | Sell |
|
|||||
|
2024
Q2 | $10.3M | Buy |
|
|||||
|
2024
Q1 | $8.2M | Sell |
|
|||||
|
2023
Q4 | $16.3M | Buy |
|
|||||
|
2023
Q3 | $4.25M | Sell |
|
|||||
|
2023
Q2 | $7.87M | Buy |
|
|||||
|
2023
Q1 | $1.68M | Sell |
|
|||||
|
2022
Q4 | $2.66M | Sell |
|
|||||
|
2022
Q3 | $14.4M | Buy |
|
|||||
|
2022
Q2 | $11.4M | Sell |
|
|||||
|
2022
Q1 | $22.7M | Buy |
|
|||||
|
2021
Q4 | $8.86M | Buy |
|
|||||
|
2021
Q3 | $3.7M | Buy |
|
|||||
|
2021
Q2 | $2.5M | Sell |
|
|||||
|
2021
Q1 | $7.52M | Buy |
|
|||||
|
2020
Q4 | $1.64M | Sell |
|
|||||
|
2020
Q3 | $2.72M | Buy |
|
|||||
|
2020
Q2 | $2.83M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $680K | Buy |
|
|||||
|
2019
Q3 | $413K | Sell |
|
|||||
|
2019
Q2 | $1.51M | Buy |
|
|||||
|
2019
Q1 | $788K | Buy |
|
|||||
|
2018
Q4 | $148K | Sell |
|
|||||
|
2018
Q3 | $785K | Sell |
|
|||||
|
2018
Q2 | $1.45M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $108K | Sell |
|
|||||
|
2017
Q3 | $213K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $10K | Sell |
|
|||||
|
2016
Q4 | $37K | Buy |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $77K | Sell |
|
|||||
|
2016
Q1 | $155K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $115K | Sell |
|
|||||
|
2015
Q2 | $362K | Sell |
|
|||||
|
2015
Q1 | $794K | Buy |
|
|||||
|
2014
Q4 | $14K | Sell |
|
|||||
|
2014
Q3 | $891K | Buy |
|
|||||
|
2014
Q2 | $25K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $781K | Buy |
|
|||||
|
2013
Q3 | $296K | Buy |
|